Company intelligence / Profile preview

Wooshin

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Wooshin Labottach is a South Korean manufacturer specializing in hydrogel patches and orally disintegrating films for pharmaceutical and cosmetic applications. The company operates two manufacturing sites—one in South Korea focused on medical device patches and oral films, and one in Slovenia producing medicated hydrogel patches under EU GMP certification. They export to over 70 countries and have robust R&D capabilities. Their portfolio includes both active pharmaceutical ingredients and finished dosage forms.

Therapeutic areas: OncologyPulmonologyMetabolic Disorders
Modalities: Patch (Hydrogel patch, Medicated patch)Orally Disintegrating FilmSmall molecule (as APIs and finished products)
Industry: Biotech

Partnerships

Collaborates with various Korean pharma companies for distribution/export/import activities

Beyond the preview

Go deeper on Wooshin.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wooshin.

Explore the full profile